do glp 1 agonists have cardiovascular benefit The effects of GLP-1 receptor beyond obesity and type 2 diabetes: An anti-atherosclerotic action Frontiers | The benefits of

This means we have a lot of evidence about both their effectiveness as well as their long-term risks.1 To finally arrive at a brisk answer to the above question: Yes, GLP-1 drugs seem like the real deal, even if the specifics of their broad benefits remain uncertain

Mounjaro was found to be more effective than Wegovy or Saxenda in a 2023 meta-analysis

Regardless of the limitations, this study provides additional support for maintaining NPO status for solids for more than 24 hours and suggests that holding GLP-1 receptor agonists for even one half-life may be beneficial

As more providers enter the space, access expands

Preclinical data demonstrate that GLP-1 and GLP-1RAs exert anti-inflammatory effects, preserve gut barrier integrity, and modulate the microbiome